• Media
  • Careers
  • Contacts
CBP - Pioneering and developing Bi-targeting XDC technologyCBPCBPCBP

Pioneering and developing Bi-targeting XDC technology

Contacts
  • Who We Are
    • About CBP
    • Our Culture
    • Leadership
    • Our History
  • Science & Innovation
    • Approach
    • Platforms
    • World of Bi-XDC
  • Pipeline
    • Pipeline
    • Clinical Trials
    • Publications
  • For Patient
    • Patient Safety
    • Clinical Sites
    • Expanded Access Policy

Yearly Archives: 2019

Author By adminPosted on June 14, 2019April 10, 2024

Coherent Biopharma Attends Signing Ceremony of “1+N” Cooperation Projects in Biopharmaceuticals in Suzhou

June 14, 2019 witnessed the signing ceremony of “1+N” cooperation projects in biopharmaceuticals hosted by Suzhou Municip...
Read More

Categories

  • News 26

Recent Posts

  • The U.S. FDA Grants Fast Track Designation to Coherent Biopharma’s CBP-1019February 23, 2025
  • The U.S. FDA Grants Fast Track Designation to Coherent Biopharma’s CBP-1008October 12, 2024
  • Coherent Biopharma’s CBP-1019 has received Orphan Drug Designation from the FDA for three indicationsJune 26, 2024
  • ASCO 2024 Highlights: Research findings of CBP-1008 and CBP-1018 once again attract global attentionJune 5, 2024
  • 【AACR 2024】Coherent Biopharma Announced Latest Pipeline CBP-8008 Preclinical Research ProgressApril 10, 2024

Archives

  • 2025 (1)
  • 2024 (5)
  • 2023 (6)
  • 2022 (4)
  • 2021 (3)
  • 2020 (4)
  • 2019 (1)
  • 2018 (2)

Meet CBP

  • Leadership
  • Our History
  • Our Culture

Science&Innovation

  • Approach
  • Platforms
  • World of Bi-XDC

Pipeline

  • Pipeline
  • Clinical Trials
  • Publications

For Patient

  • Patient Safety
  • Clinical Sites
  • Expanded Access Policy
Copyright © 2025 CBP  All rights reserved.